Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Amylyx Pharmaceuticals, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
AMLX
Nasdaq
2830
amylyx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Amylyx Pharmaceuticals, Inc.
Should Eli Lilly Investors Be Worried About a Threat From Amylyx?
- Aug 30th, 2026 10:35 am
Oracle Stock And 2 High Growth Picks Backed By Rising Credit Demand
- Aug 27th, 2026 10:24 am
Oracle Stock And 2 Growth Picks With Strong Earnings Potential
- Aug 25th, 2026 10:38 pm
Why Amylyx Pharmaceuticals Blasted Nearly 79% Higher This Week
- Aug 21st, 2026 4:00 pm
Amylyx (AMLX) Faces a Binary Phase 3 Test. Can Avexitide Rebuild the Company?
- Aug 21st, 2026 3:58 pm
Why Did IOVA, AMLX And COP Stocks Surge To 52-Week Highs Today?
- Aug 20th, 2026 9:57 pm
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
- Aug 19th, 2026 9:06 pm
AMLX Rises as Avexitide Nears 2026-End Filing With Phase III Study Win
- Aug 19th, 2026 10:18 am
Amylyx Pharmaceuticals (AMLX) Posts Phase 3 Avexitide Win And Follows With Equity Raise
- Aug 19th, 2026 3:11 am
Why Did AMLX, IOVA, OKE Stocks Hit 52-Week Highs Today?
- Aug 18th, 2026 7:54 pm
Amylyx (AMLX) Climbs to Fresh High as Avexitide Moves Closer to Commercialization
- Aug 18th, 2026 5:44 pm
Why Amylyx Pharmaceuticals Stock Skyrocketed Today
- Aug 18th, 2026 5:30 pm
AMLX Stock Clocks Best Day Ever After Positive Trial Data, Launches $350M Offering
- Aug 18th, 2026 3:31 pm
Micron, Coherent, SpaceX, Klarna, Amylyx, and More Stocks That Explain Today’s Market
- Aug 18th, 2026 2:27 pm
A New Use for GLP-1s? Amylyx Pharma Catapults To 3-Year High
- Aug 18th, 2026 2:26 pm
AMLX Stock Soars as Amylyx GLP-1 Drug Succeeds in Late-Stage Trial
- Aug 18th, 2026 2:10 pm
Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock
- Aug 18th, 2026 2:01 pm
Sector Update: Healthcare Stocks Climb Late Afternoon
- Aug 18th, 2026 1:51 pm
Scroll